Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial - de Bruyn, G; Gordon, DL; Steiner, T (Lancet Infect Dis, 2021)